Reuters logo
BRIEF-Kadmon submits 2nd abbreviated new drug application filing for trientine hydrochloride to FDA
April 4, 2017 / 1:27 PM / 8 months ago

BRIEF-Kadmon submits 2nd abbreviated new drug application filing for trientine hydrochloride to FDA

April 4 (Reuters) - Kadmon Holdings Inc:

* Kadmon submits second abbreviated new drug application filing for trientine hydrochloride to FDA

* Kadmon Holdings Inc - product to offer room temperature storage, representing advantage over currently marketed formulations Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below